Results 131 to 140 of about 40,312 (250)

Naltrexone-bupropion for weight loss [PDF]

, 2023
Betsy Thomas, Adrienne J. Lindblad, Thao Luu, Allison Paige   +3 more
openalex   +1 more source

Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives

Patient Preference and Adherence, 2016
Cenk Tek Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA Abstract: Naltrexone, an opiate antagonist, and bupropion, a noradrenergic/dopaminergic antidepressant, have many effects on the reward systems of the brain.
Tek C
doaj  

Rapid Antidepressant Effects and MADRS Item Improvements With AXS-05 (DEXTROMETHORPHAN-BUPROPION), an Oral NMDA Receptor Antagonist in Major Depressive Disorder: Results From Two Randomized Double-Blind, Controlled Trials [PDF]

, 2023
Amanda Jones, Caroline Streicher, Shawn Alter, Zachariah Thomas, Herriot Tabuteau   +4 more
openalex   +1 more source

Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study [PDF]

, 2017
Aim To investigate the safety and efficacy of bupropion sustained release (bupropion SR) in promoting abstinence from smoking in subjects with cardiovascular disease (CVD).
Astbury, C., Farsang, C., Hider, A., Klaene, G., Lewis, K., Manolis, A., Perruchoud, A.P., Silagy, C., Sweet, R., Tonstad, S., van Spiegel, P.I.   +10 more
core  

Efficacy and safety of bupropion in quality of life of cancer patients, a randomized double blind placebo controlled clinical trial

Journal of Mazandaran University of Medical Sciences, 2019
Background and purpose: Decreasing the quality of life in cancer patients is an essential factor that influences their lives during the process of treatment and after that.
Saeid Azimi, Ebrahim Salehifar, Ghasem Janbabai, Ehsan zaboli, Narjes Hendouei, Fatemeh Saghafi, Samaneh Borhani   +6 more
doaj  

Polymorphic Variants of Cytochrome P450 2B6 (CYP2B6.4–CYP2B6.9) Exhibit Altered Rates of Metabolism for Bupropion and Efavirenz: A Charge-Reversal Mutation in the K139E Variant (CYP2B6.8) Impairs Formation of a Functional Cytochrome P450-Reductase Complex [PDF]

, 2011
Haoming Zhang, Chitra Sridar, Cesar Kenaan, Hemali Amunugama, David P. Ballou, Paul F. Hollenberg   +5 more
openalex   +1 more source

Vareniclina. Un paso más en la lucha contra el tabaquismo [PDF]

, 2007
Recientemente la Food and Drugs Administration ha aprobado Vareniclina, fármaco para la deshabituación tabáquica que presenta un novedoso mecanismo de acción, agonismo parcial de receptores nicotínicos de acetilcolina a4ß2.Hemos revisado la farmacología,
Donat, Lucas, Ferrando Piqueres, Raúl, Martínez, Beatriz, Milara Payá, Javier, Pérez Prior, Noemí, Soler Company, Enrique   +5 more
core  

Varenicline and Bupropion for Long-Term Smoking Cessation (the MATCH Study): Protocol for a Real-World, Pragmatic, Randomized Controlled Trial [PDF]

, 2018
Laurie Zawertailo, Tara Mansoursadeghi-Gilan, Helena Zhang, Sarwar Hussain, Bernard Le Foll, Peter Selby   +5 more
openalex   +1 more source

Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial

, 2022
Carlos M. Grilo, Janet A. Lydecker, Sarah K. Fineberg, Jorge O. Moreno, Valentina Ivezaj, Ralitza Gueorguieva   +5 more
openalex   +2 more sources

Nicotine oxidation by genetic variants of CYP2B6 and in human brain microsomes [PDF]

, 2019
Bloom, Adam Joseph, Kharasch, Evan D, Wang, Pan-Fen   +2 more
core   +2 more sources